Our Business development provides another source of synergies, allowing us to stay at the forefront of launching unique products and innovation in the industry. Citron Pharma is actively licensing approved pharmaceutical ANDA products to be marketed and distributed in the US. We seek organic growth that will be supported by acquisitions and partnerships.
We have successful strategic partnerships with multinational organizations that wish to divest both branded and generic products.
We look forward for similar & innovative collaborations and pave the path for win-win business relationships in distinct therapies and key markets